Complement in neuroprotection and neurodegeneration

被引:53
|
作者
Yanamadala, Vijay [1 ]
Friedlander, Robert M. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Neuroapoptosis Lab,Dept Neurosurg, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
APOPTOTIC CELL-DEATH; ANAPHYLATOXIN C5A; PROTECTS OLIGODENDROCYTES; ALZHEIMERS-DISEASE; EXPRESSION; RECEPTOR; ACTIVATION; SYSTEM; NEURONS; BRAIN;
D O I
10.1016/j.molmed.2009.12.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute neurodegeneration is associated with high morbidity and mortality, and there are few effective treatments. Inflammation is central to the process of neuronal death, yet the roles of the complement cascade in this process have proven to be complex and hard to unravel. The complement cascade is involved in triggering cell death and recruiting cells of the immune system to sites of inflammation, including the brain. However, complement might also have important neuroprotective roles that are only now coming to light. Recent evidence suggests that targeted activation of complement might be a potential approach for treatment of stroke and other acute neurodegenerative diseases. Here, we review these novel neuroprotective roles of the complement cascade, focusing on signaling pathways that might provide new therapeutic targets in acute neuronal injury.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 50 条
  • [1] Activation of complement in the central nervous system - Roles in neurodegeneration and neuroprotection
    Van Beek, J
    Elward, K
    Gasque, P
    [J]. NEUROENDOCRINE AND NEURAL REGULATION OF AUTOIMMUNE AND INFLAMMATORY DISEASE: MOLECULAR, SYSTEMS, AND CLINICAL INSIGHTS, 2003, 992 : 56 - 71
  • [2] Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection
    Gasque, P
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 16 - 16
  • [3] Adenosine, neurodegeneration and neuroprotection
    Stone, TW
    [J]. NEUROLOGICAL RESEARCH, 2005, 27 (02) : 161 - 168
  • [4] NEUROPROTECTION IN NEURODEGENERATION - PREFACE
    RIEDERER, P
    FRITZE, J
    YOUDIM, MBH
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1994, (43): : R5 - R6
  • [5] BMAA, Neurodegeneration, and Neuroprotection
    Paul Alan Cox
    [J]. Neurotoxicity Research, 2021, 39 : 1 - 5
  • [6] BMAA, Neurodegeneration, and Neuroprotection
    Cox, Paul Alan
    [J]. NEUROTOXICITY RESEARCH, 2021, 39 (01) : 1 - 5
  • [7] Tryptophan, adenosine, neurodegeneration and neuroprotection
    Stone, T. W.
    Forrest, C. M.
    Mackay, G. M.
    Stoy, N.
    Darlington, L. G.
    [J]. METABOLIC BRAIN DISEASE, 2007, 22 (3-4) : 337 - 352
  • [8] Neurodegeneration and Neuroprotection in Parkinson Disease
    Fahn S.
    Sulzer D.
    [J]. NeuroRX, 2004, 1 (1): : 139 - 154
  • [9] Unconventional neurotransmitters, neurodegeneration and neuroprotection
    Leonelli, M.
    Torrao, A. S.
    Britto, L. R. G.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2009, 42 (01) : 68 - 75
  • [10] Glaucomatous neurodegeneration and the concept of neuroprotection
    Bautista, RD
    [J]. INTERNATIONAL OPHTHALMOLOGY CLINICS, 1999, 39 (03) : 57 - 70